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Abstract: 
Background: All around the globe, the third most contributing factor to death from cancer is hepatocellular 
carcinoma. 
Objective: To examine activated aspects among patients of hepatocellular carcinoma (HCC) at a tertiary care centre 
in the previous two years was the purpose of this research. 
Material and Methods: We carried out this research at Mayo Hospital, Lahore from January 2017 to August 2018. 
The patients selected for this study were having HCC identified by histopathology or tumour marker. These patients 
were examined. Level of alpha-fetoprotein, the presence of cirrhosis, distribution of liver lesions, positivity for 
hepatitis serology and size of tumour were observed and demographic aspects were noticed. 
Results: Histopathology and tumour marker proved HCC was observed in 192 patients. The number of males and 
females were 149 (77.6%) and 43 (22.4%) respectively. 27 (14%) cases were found positive for hepatitis B surface 
antigen. 138 (72%) patients were positive for HCV. Multicentric distribution was observed in 117 (61%) patients. 134 
(70%) patients were noted with cirrhosis and increased level of alpha-fetoprotein was observed in 154 (84%). 16 (8%) 
patients were found with dual hepatitis (HBV + HCV). The people without any reason were 11 (6%). 
Conclusion: the results concluded that in most patients, hepatitis C virus infection is associated with hepatocellular 
carcinoma. The males were more vulnerable to this disorder and it was observed in the fifth and sixth decade of life. 
Cirrhosis, multicentric and advanced disorder at presentation were observed in the majority of the patients. 
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INTRODUCTION: 
All around the globe, the third most contributing factor 
to death from cancer is hepatocellular carcinoma. It is 
also the fifth most frequently found malignancy [1]. 
Worldwide, there is a high incidence of HCC and 
chronic hepatitis C virus (HCV). The chronic liver 
disorder is caused by HCV [1]. The incidence of all 
primary liver malignancies due to HCC is between 
60% and 90% in developing countries. In these 
countries, death is mostly caused by HCC [2]. Based 
on the report of the World Health Organization, HCV 
infects about 160 million people all over the world. 
Most of these people belong to the developing nations. 
For cirrhosis and hepatocellular carcinoma, the factor 
that is significantly responsible for HCV. It is due to 
the fact that the incidence of HCV related liver is high 
even in developed nations [3]. The reasons reported in 
various studies of HCC conducted in the previous ten 
years in Pakistan have been aflatoxins and viral 
hepatitis [4]. In patients of hepatocellular carcinoma, 
HBsAg was positive in about 60% based on the results 
of previous studies [5]. On the other hand, the 
incidence of positivity of hepatitis C virus infection 
was reported as 80% according to the results of current 
studies [6]. In various nations, there exists a difference 
in the clinical aspects, survival of hepatocellular 
carcinoma and causes [7]. To examine activated 
aspects among patients of hepatocellular carcinoma 
(HCC) at a tertiary care centre in the previous two 
years was the purpose of this study. 
 
PATIENTS AND METHODS: 
We carried out this research at Mayo Hospital, Lahore 
from January 2017 to August 2018. The patients 
selected for this study were having HCC identified by 
histopathology or tumour marker. These patients were 
examined. Level of alpha-fetoprotein, the presence of 
cirrhosis, distribution of liver lesions, positivity for 
hepatitis serology and size of the tumor were observed 
and demographic aspects were noticed. Features such 
as the presence of hepatitis B surface antigen, anti 
HCV antigen and demographic aspects were also 
observed. 
 
RESULTS: 
Histopathology and tumour marker proved HCC was 
observed in 192 patients. The number of males and 
females were 149 (77.6%) and 43 (22.4%) 
respectively. 27 (14%) cases were found positive for 
hepatitis B surface antigen. 138 (72%) patients were 
positive for HCV. Multicentric distribution was 
observed in 117 (61%) patients. 134 (70%) patients 
were noted with cirrhosis and increased level of alpha-
fetoprotein was observed in 154 (84%). 16 (8%) 
patients were found with dual hepatitis (HBV + HCV). 
The people without any reason were 11 (6%). Detailed 
outcomes analysis is given in Table – I & II: 
 
Table – I: Gender Distribution 
 
Gender Number Percentage 
Males    149 77.6 
Females   43 22.4 
 
 
 
149
43
77.6
22.4
-50 0 50 100 150 200 250
Males
Females
Percentage Number
IAJPS 2019, 06 (03), 6150-6153            Abdul Rehman Sarwar et al               ISSN 2349-7750 
 
 
 
w w w . i a j p s . c o m  
 
Page 6152 
 
Table – II: Clinicopathological Features 
 
Features    Number Percentage 
HBsAg    27 14 
HCV Ab    138 72 
Both HBV & HCV 16 8 
Unknown aetiology   11 6 
AFP elevation   154 84 
Cirrhosis   134 70 
Multicentric   117 61 
 
 
 
 
DISCUSSION: 
Various studies are conducted in different regions of 
Pakistan. These studies indicated the range of age 
between 17 – 84 years. The number of males in our 
study was 89%. In the studies held previously, 87% of 
patients were found with anti HCV and 69% of 
patients were positive for Hepatitis B surface antigen 
[8]. In Pakistan and various other developed nations of 
Asia and Africa, aflatoxin contamination has also been 
observed along with hepatitis B and hepatitis C virus 
infection [4]. In 84% of cases, there observed an 
increased level of fetoprotein. In one study, the cases 
found with cirrhosis were 86% [9]. Cirrhosis and 
chronic hepatitis result from hepatitis C virus infection 
and as a result, it leads to HCC. 
 
The time duration between the establishment of HCV 
infection and hepatocellular carcinoma is long [10]. 
Hepatic carcinogenesis is significantly caused by 
hepatitis B. The incidence is increased many times by 
the presence of HBsAg [11]. Diabetes mellitus and 
synergism of alcohol with viral hepatitis are other 
causes of hepatocarcinogenesis [12]. As compare to 
identical study in Germany, there are a deficiency of 
correlation between alpha-fetoprotein and size of the 
tumor in various studies conducted in Pakistan [13]. 
According to the results of the current study, alpha-
fetoprotein was increased in 84% of cases. Elevated 
tumour marker, FNAC, radiological results and liver 
biopsy were the basis of identification in our study. 
Seventy percent of our cases were presented with 
multicentric tumours. This has been due to a valuable 
number of patients with chronic hepatitis C. In 
Germany, it is 90% and 76% in India [13, 14]. The 
establishment cirrhosis is associated with alcoholism 
along with hepatitis B and C. As a result, it contributes 
to HCC [15]. In rural areas of Southern Punjab, testing 
for HCV is less common. The main reason of HCV 
transmission in this area is still the blood transfusions. 
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CONCLUSION: 
It is concluded that the most common malignancy is 
hepatocellular carcinoma. The major reason is HCV as 
it presents with advanced stage. The males were 
vulnerable to this disorder and it was observed in the 
fifth and sixth decade of life. In most of the patients, 
Anti HCV has been found, 6% of cases had 
multilocular presentation. Cirrhosis was present in 
seventy percent patients. Alpha-fetoprotein was 
elevated in above 80% of cases. 
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